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Technical background
Several studies using trigger high mechanical index (MI) techniques for visualization of cerebral perfusion after ultrasound contrast agent (UCA) injection have been published in the last 13 years [1] [2] [3] [4] [5] [6] . The studies were mostly performed with triggered harmonic gray scale imaging techniques (conventional, power modulation or pulse-inversion) analyzing Abbreviations: A, fractional vascular volume related to the plateau echo enhancement (refill kinetics); AUC, area under the curve;ˇ, rate constant (slope of the wash in curve of refill kinetics); FWHM, full width at half the maximum intensity; IU, intensity units (linear scale); MI, mechanical index; MTT, mean transit time; PG, positive gradient; PI, peak intensity; PPI, pixelwise peak intensity; PSI, peak signal increase; PW, peak width; ROI, region of interest; TPI, time to peak intensity; TTP, time between start of contrast signal and peak intensity; UCA, ultrasound contrast agent. * Tel.: +49 040 18 18 87 3076; fax: +49 040 18 18 87 3069. E-mail address: g.seidel@asklepios.com the bolus kinetics in healthy subjects to find out the best way for the detection of UCA in the cerebral microcirculation.
Recently low mechanical index gray scale imaging was introduced. With this new real-time technology bolus kinetics as well as refill kinetics could be analyzed. Refill kinetics is based on the reappearance of echo contrast in tissue after complete microbubble destruction using a high MI pulse. After destruction of the contrast agent within the scanning plane new microbubbles enter the volume with a certain velocity, thus allowing calculation of regional blood flow ( Fig. 1 ). Refill kinetics to measure regional cerebral blood flow was first studied in dogs after craniectomy [7] . Recent technological advances in ultrasound equipment with improved sensitivity for detection of microbubbles in the cerebral microcirculation through the acoustic bone window in humans now enable real-time ultrasound perfusion imaging [8, 9] . This new real-time refill technology has several advantages over the triggered high MI techniques. First refill kinetics could be recorded and analyzed within seconds (Fig. 2) ; therefore, several insonation planes could be evaluated with one contrast bolus injection. Second software tools like microvascular imaging (display of the 2211-968X © 2012 Elsevier GmbH. doi:10.1016/j.permed.2012.02.041
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Figure 1
Schematic representation of different parameters of the time-intensity curve available from bolus kinetics (left) and refill kinetics (right). (a) Bolus kinetics: ROI = region of interest, IU = intensity units (linear scale), PI = peak intensity, PG = positive gradient, PSI = peak signal increase, PW = peak width, FWHM = full width at half the maximum intensity, AUC = area under the curve, TPI = time to peak intensity, TTP = time between start of contrast signal and peak intensity, MTT = mean transit time. (b) Refill kinetics:ˇ= rate constant (slope of the wash in curve), A = fractional vascular volume related to the plateau echo enhancement. Adapted from [11] . amount of contrast signals over time [8] ) help in visualization and documentation of perfusion deficits. On the other hand there are some disadvantages like the limited maximal insonation depth and the high rate of insonation artifacts.
As of yet, it is not evident which method is superior for the analysis of brain perfusion, because studies with a direct comparison are missing.
Figure 2
Microvascular imaging: captured contrast signals over 8 s after destruction pulse using low MI real time contrast imaging (iU22 ultrasound system) in a 41-year-old female patient suffering from middle and anterior cerebral artery infarction 11.5 h after symptom onset. We used 2.4 ml SonoVue TM as a bolus. MRI scan (DWI, below) was performed 20 min after the ultrasound perfusion study. Notice the insonation plane within the yellow margins. The area of diffusion disturbance in the MRI (white area) showed no contrast signal in the ultrasound perfusion study (dark area).
The commercially available ultrasound contrast agents Levovist TM (Schering), Optison TM (Amersham Health), and SonoVue TM (Bracco) proved to have contrast enhancing properties in human brain perfusion imaging. No severe adverse events were documented in numerous volunteer studies published on brain perfusion analysis using these contrast agents including more than 200 subjects.
Various curve parameters have been described for the analysis of the different contrast kinetics (bolus and refill). To date (12/2011), it is not evident which kinetics or which parameter is the most valuable for the analysis of brain perfusion in healthy subjects. Theoretically, timedependent parameters like time to peak intensity (bolus kinetics) or theˇ-value (refill kinetics) should be more useful than amplitude-dependent parameters, because the latter depend also on insonation depth. Parametric images of certain properties of the time-intensity curves have been generated, which facilitate the evaluation of regional brain perfusion ( Fig. 3 ) [6] .
Several studies were reported on ultrasound perfusion imaging in healthy volunteers using perfusion weighted MRI as reference for ultrasound perfusion imaging (Contrast Burst and Time Variance Imaging as well as high MI harmonic imaging) [5, 10] . In these studies the time to peak intensity and in one study [5] the area under the time-intensity curve of ultrasound perfusion imaging showed a good correlation to the time to peak intensity as measured in perfusion weighted MRI.
Stroke studies
In most clinical studies on ischemic stroke patients contrast bolus kinetics was analyzed using different high MI harmonic imaging modalities (harmonic imaging, power modulation, and pulse inversion imaging). Levovist TM , Optison TM , and SonoVue TM were used as contrast agents [12] [13] [14] [15] [16] . With new, more sensitive multi-pulse ultrasound technologies it is possible to analyze brain perfusion not only in the ipsilateral but also in the contralateral hemisphere within one investigation improving the geometry of the insonation plane and overcoming near-field artifacts [16] . When using this approach, additional artifacts (calcification of pineal gland
Figure 3
Ultrasound perfusion study using parametric imaging (high-MI imaging, 2.4 ml SonoVue TM bolus kinetics). Ultrasound (SONOS 5500, Philips) was performed 6 h after symptom onset in a 70-year-old male patient suffering from MCA occlusion (M1segment). Upper row: Time-to-peak image (TTP) and peak signal increase image (PPI--pixelwise peak intensity). Notice the area of delayed contrast arrival in the TTP image (within the red line), which showed in the anterior section a decrease of contrast amplitude in the PPI image. CCT follow-up in the same imaging plane as investigated by ultrasound is shown in the lower row. In the follow-up 180 h after symptom onset a complete middle cerebral artery infarction was displayed, which fits with the initial delay of contrast arrival in the TTP image. and choroid plexus of lateral ventricles causing shadowing artifacts) have to be considered.
In recent low MI real time refill kinetics studies [17, 18] perfusion deficits in acute ischemic stroke patients could be visualized qualitatively with high sensitivity in the ipsilateral hemisphere. The maximal area without detectable contrast signal correlates with the severity of stroke symptoms [17] . Besides this, quantitative thresholds for the occurrence of ischemia were calculated (ˇ< 0.76 and A ×ˇ< 1.91 [18] ).
Different parameters of the bolus kinetics curve acquired from ischemic brain regions in the acute phase of stroke were compared with follow-up CT to visualize the infarction. A combination of the peak intensity increase (PI) and timeto-peak (TTP) proved to be most helpful in detecting the area of infarction, with a sensitivity between 75% and 86% as well as a specificity between 96% and 100% [13, 15] .
In more recent studies color-coded parametric images were evaluated [12, 19] . They provide information on the time-intensity data in all pixels under evaluation, thus facilitating the visualization of the perfusion state [19] . Although the supplying artery was found patent by colorcoded duplex, in 13-14% of acute ischemic stroke patients a perfusion deficit in the middle cerebral artery territory could be identified with parametric perfusion imaging [13, 19] . The areas of disturbed perfusion in the parametric images (especially the PPI image) correlate with the area of infarction in follow-up CT and the severity of stroke symptoms in the early phase as well as after four months [16] . Some more investigations based on contrast bolus kinetics were performed on smaller populations using Xenon-CT [20] and MRI [14] as reference methods. These case reports demonstrate the potential of different contrast-specific modalities for the assessment of pathologic brain perfusion using contrast ultrasound imaging. In a small study analyzing local correlations of ultrasound perfusion parameters of bolus kinetics with the occurrence of a perfusion-diffusion mismatch on Stroke MRI (penumbra) thresholds were calculated. Penumbra could be assumed if the relative time delay exceeded 4 s and the relative signal amplitude exceeded 1/3 [21] . These preliminary data should be verified by a prospective study.
Besides the high potential of ultrasound perfusion imaging as a fast, semi-invasive bedside method to evaluate supratentorial brain perfusion in acute ischemic stroke patients, there are some drawbacks like the insonation artifacts, which occur in most of the patients and the inability to scan the whole brain. Besides these technical limitations there are potential side effects of the new contrast agents, which restrict the employment of these substances in severe cardiac or pulmonary disease.
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